Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Eur J Gynaecol Oncol ; 34(1): 48-50, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23590000

RESUMEN

BACKGROUND: The authors aimed to confirm the depth of six mm in order to achieve an optimal eradication of the lesion. MATERIALS AND METHODS: This is a retrospective observational study of 94 cervical surgical pieces from women aged 17 to 22 years with a cyto-colpo-histopathological diagnosis of high-grade squamous cervical intraepithelial neoplasia (CIN II and/or CIN III) submitted to large loop excision of transformation zone (LLETZ). The glandular crypts and margins, both exposed or not to CIN, were assessed. The compromise and the maximum depth of the glandular crypts were noticed. RESULTS: After LLETZ, 23 (24.47%) cases presented a neoplasic impairment of endocervical margin and ten (10.64%) of the ectocervical margin. The largest noticed crypt measured 4.500 mm and the shortest 0.100 mm, with an average of 2.148 mm. CONCLUSIONS: Squamous CIN more frequently show the exposure of surgical margins to LLETZ. The deeper location of glandular crypts in the cases studied was 4.500 mm, while the largest neoplastic extension was 3.000 mm.The therapeutic method depends on this knowledge.


Asunto(s)
Cuello del Útero/cirugía , Displasia del Cuello del Útero/cirugía , Neoplasias del Cuello Uterino/cirugía , Adolescente , Adulto , Anciano , Femenino , Humanos , Persona de Mediana Edad , Estudios Retrospectivos , Neoplasias del Cuello Uterino/patología , Displasia del Cuello del Útero/patología
2.
Transplant Proc ; 44(8): 2300-3, 2012 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-23026579

RESUMEN

To study whether treatment with heparin (HEP) attenuates intestinal dysfunction caused by ischemia (I) and reperfusion (R), rats were treated with HEP (100 U/kg intravenously) or saline solution (SS) before I (60 min), which was produced by occlusion of the superior mesenteric artery, and R (120 min). After I or I/R, we mounted 2-cm jejunal segment in an organ bath to study neurogenic contractions stimulated by electrical pulses or KCl, using a digital recording system. Thin jejunal slices were stained with hematoxylin and eosin for optical microscopy. Compared with the sham group, jejunal contractions were similar in the I + HEP and the I/R + HEP groups, but reduced in the I + SS and the I/R + SS groups. The jejunal enteric nerves were damaged in the I + SS and the I/R + SS, but not in the I + HEP and the I/R + HEP cohorts. These results suggested that HEP attenuated intestinal dysfunction caused by I and I/R.


Asunto(s)
Fármacos Gastrointestinales/farmacología , Heparina/farmacología , Yeyuno/irrigación sanguínea , Yeyuno/efectos de los fármacos , Daño por Reperfusión/prevención & control , Animales , Citoprotección , Modelos Animales de Enfermedad , Estimulación Eléctrica , Sistema Nervioso Entérico/efectos de los fármacos , Sistema Nervioso Entérico/fisiopatología , Motilidad Gastrointestinal/efectos de los fármacos , Yeyuno/inervación , Yeyuno/patología , Yeyuno/fisiopatología , Masculino , Cloruro de Potasio/farmacología , Ratas , Ratas Wistar , Daño por Reperfusión/patología , Daño por Reperfusión/fisiopatología
3.
Transplant Proc ; 44(8): 2304-8, 2012 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-23026580

RESUMEN

To study whether ischemic preconditioning (IPC) attenuated intestinal dysfunction caused by ischemia (I) and reperfusion (R), rats were underwent 60 minutes of I which was produced by occlusion of the superior mesenteric artery, and/or 120 minutes R. The IPC group had the I procedure previously stimulated for 5 minutes and the R for 10 minutes. IPC and sham groups were injected with saline solution (SS) via the femoral vein 5 minutes before the I and R, and for R. After I or I/R, 2-cm jejunal segments were mounted in an organ bath to study neurogenic contractions stimulated by electrical pulses or KCl using a digital recording system. Thin jejunal slices were stained with hematoxylin and eosin for optical microscopy. Compared with the sham group, jejunal contractions were similar in the IPC + I and the IPC + I/R groups, but reduced in the I + SS and the I/R + SS groups. The jejunal enteric nerves were damaged in the I + SS and the I/R + SS groups, but not in the IPC groups. These results suggested that ischemic preconditioning attenuated intestinal dysfunction caused by I and I/R.


Asunto(s)
Precondicionamiento Isquémico , Yeyuno/irrigación sanguínea , Daño por Reperfusión/prevención & control , Animales , Modelos Animales de Enfermedad , Estimulación Eléctrica , Sistema Nervioso Entérico/fisiopatología , Motilidad Gastrointestinal , Yeyuno/efectos de los fármacos , Yeyuno/inervación , Yeyuno/patología , Yeyuno/fisiopatología , Masculino , Cloruro de Potasio/farmacología , Ratas , Ratas Wistar , Daño por Reperfusión/patología , Daño por Reperfusión/fisiopatología
4.
Transplant Proc ; 44(8): 2309-12, 2012 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-23026581

RESUMEN

To examine whether treatment with L-arginine (ARG), a substrate of nitric oxide biosynthesis, attenuated intestinal dysfunction caused by ischemia (I) and reperfusion (R), we treated rats with ARG (100 mg/kg intravenously) or saline solution (SS) before 60 minutes of I produced by occlusion of the superior mesenteric artery and/or during 120 minutes of R. After I or I/R, we isolated 2-cm jejunal segments for mounting in an organ bath to study neurogenic contractions stimulated by electrical pulses or KCl with the use of a digital recording system. Thin jejunal slices were stained with hematoxylin and eosin for optical microscopy. Jejunal contractions were similar in the sham and I+ARG, but reduced in I+SS, I/R+SS, and I/R+ARG groups. Jejunal enteric nerves were damaged in I+SS, IR+SS, and IR+ARG, but not in the I+ARG group, suggesting that ARG attenuate intestinal dysfunctions due to I but not to R.


Asunto(s)
Arginina/farmacología , Fármacos Gastrointestinales/farmacología , Yeyuno/irrigación sanguínea , Yeyuno/efectos de los fármacos , Daño por Reperfusión/tratamiento farmacológico , Animales , Citoprotección , Modelos Animales de Enfermedad , Estimulación Eléctrica , Sistema Nervioso Entérico/efectos de los fármacos , Sistema Nervioso Entérico/fisiopatología , Motilidad Gastrointestinal/efectos de los fármacos , Yeyuno/inervación , Yeyuno/patología , Yeyuno/fisiopatología , Masculino , Cloruro de Potasio/farmacología , Ratas , Ratas Wistar , Daño por Reperfusión/patología , Daño por Reperfusión/fisiopatología
5.
Transplant Proc ; 44(8): 2317-20, 2012 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-23026583

RESUMEN

To study whether treatment with adenosine (ADO), an agonist of adenosine receptors, attenuates intestinal dysfunction caused by ischemia (I) and reperfusion (R), we treated rats with ADO (15 mg/kg or saline solution (SS) intravenously before 60 minutes occlusion of the superior mesenteric artery (I) and/or 120 minutes after its release (R). After I or I/R, isolated jejunal segments (2 cm) were mounted in an organ bath to study nerve-mediated contractions stimulated by electrical pulses or KCI with the use of a digital recording system. Thin jejunal slices were stained with hematoxylin and eosin for optical microscopy. Compared with the sham group, jejunal contractions were reduced in I+SS and IR+SS but similar after treatment with ADO (I+ADO and IR+ADO groups). We concluded that rat jejunal enteric nerves were damaged in I+SS and IR+SS but not in the I+ADO and IR+ADO groups. These results suggested that ADO attenuated intestinal dysfunction due to I and R.


Asunto(s)
Adenosina/farmacología , Fármacos Gastrointestinales/farmacología , Yeyuno/irrigación sanguínea , Yeyuno/efectos de los fármacos , Daño por Reperfusión/prevención & control , Animales , Citoprotección , Modelos Animales de Enfermedad , Estimulación Eléctrica , Sistema Nervioso Entérico/efectos de los fármacos , Sistema Nervioso Entérico/fisiopatología , Motilidad Gastrointestinal/efectos de los fármacos , Yeyuno/inervación , Yeyuno/patología , Yeyuno/fisiopatología , Cloruro de Potasio/farmacología , Ratas , Ratas Wistar , Daño por Reperfusión/patología , Daño por Reperfusión/fisiopatología
6.
Transplant Proc ; 44(8): 2313-6, 2012 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-23026582

RESUMEN

To study whether treatment with the beta-blocker atenolol (AT) attenuates intestinal dysfunction caused by ischemia (I) and reperfusion (R), rats were treated with AT (1.5 mg · kg(-1), intravenously) or saline solution (SS) prior to I (60 minutes), which was produced by occlusion of the superior mesenteric artery, and/or R (120 minutes). After I or I/R, 2-cm jejunal segments were mounted in an organ bath to study neurogenic contractions stimulated by electrical pulses or KCl using a digital recording system. Thin jejunal slices were stained with hematoxylin and eosin for optical microscopy analysis. Compared to the sham group, jejunal contractions were similar in the I + AT and the I/R + AT groups, but reduced in the I + SS and the I/R + SS groups. The jejunal enteric nerves were damaged in the I + SS and the I/R + SS groups, but not in the I + AT and the I/R + AT. These results suggest that AT may attenuate intestinal dysfunction caused by I and I/R.


Asunto(s)
Antagonistas de Receptores Adrenérgicos beta 1/farmacología , Atenolol/farmacología , Fármacos Gastrointestinales/farmacología , Yeyuno/irrigación sanguínea , Yeyuno/efectos de los fármacos , Daño por Reperfusión/prevención & control , Animales , Citoprotección , Modelos Animales de Enfermedad , Estimulación Eléctrica , Sistema Nervioso Entérico/efectos de los fármacos , Sistema Nervioso Entérico/fisiopatología , Motilidad Gastrointestinal/efectos de los fármacos , Yeyuno/inervación , Yeyuno/patología , Yeyuno/fisiopatología , Masculino , Cloruro de Potasio/farmacología , Ratas , Ratas Wistar , Daño por Reperfusión/patología , Daño por Reperfusión/fisiopatología
7.
Eur J Gynaecol Oncol ; 31(4): 459-61, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-20882896

RESUMEN

PURPOSE: This study aimed to evaluate the immunoexpression of granzyme B and vascular endothelial growth factor (VEGF) in the variants of cervical squamous intraepithelial neoplasia. METHODS: Granzyme B immunohistochemical expression was studied in the epithelium, stroma and in both the epithelium + stroma of 142 fragments of uterine cervix; there were 34 grade 1 cervical intraepithelial neoplasias (CIN 1), 36 grade 2 cervical intraepithelial neoplasias (CIN 2), 33 grade 3 cervical intraepithelial neoplasias (CIN 3) and 39 uterine cervix fragments without abnormalities - control group. Immunoexpression of VEGF was studied in 160 uterine cervix fragments, with 43 grade 1 cervical intraepithelial neoplasias (CIN 1), 33 grade 2 cervical intraepithelial neoplasias (CIN 2), 31 grade 3 cervical intraepithelial neoplasias (CIN 3) and 53 uterine cervix fragments without abnormalities--control group. RESULTS: In the stroma, immunoexpression of granzyme B in grade 1 cervical intraepithelial neoplasias was smaller than in grade 3 cervical intraepithelial neoplasias. High VEGF immunoexpression was found in grade 3 cervical intraepithelial neoplasias while it was low in grade 1 cervical intraepithelial neoplasias and in the control group. CONCLUSION: The higher the severity of the cervical intraepithelial lesion, the higher the immunoexpression of granzyme B. A progressive increase in VEGF immunoexpression was found in the intense grade, according to the severity of the cervical intraepithelial neoplasia.


Asunto(s)
Carcinoma de Células Escamosas/química , Cuello del Útero/química , Granzimas/análisis , Displasia del Cuello del Útero/química , Neoplasias del Cuello Uterino/química , Factores de Crecimiento Endotelial Vascular/análisis , Femenino , Humanos , Inmunohistoquímica
8.
Clin Exp Obstet Gynecol ; 32(2): 138-40, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-16108402

RESUMEN

A case report of a HIV seropositive 8-year-old child with vulvar and anal border neoplasia, both grade 3, and the adopted therapeutic management are presented. The mother reported the history of a progressively growing verrucous lesion in the vulva since the age of three and a half years. On physical examination a pigmented and elevated lesion was observed in the whole vulvar region extending to the anal region and intergluteal sulcus. After biopsies and anatomic pathological examination, antiretroviral therapy, adequate for age, and topical application of podophyllotoxin associated with Thuya officinalis extract was started. Three months afterwards vaporization and CO2 laser excision were performed in five sequential sessions, thereafter associated with topical imiquimod application. After the first two sessions of laser therapy early relapses occurred. After four weeks of imiquimod use, already a significant improvement of the lesions was observed, making the following laser therapy sessions easier. We conclude that antiretroviral therapy associated with podophyllotoxin and Thuya was not effective regarding regression of the lesions. Laser therapy alone led to early relapses. The local use of imiquimod associated with laser was effective in decreasing and controling the lesions.


Asunto(s)
Neoplasias del Ano/terapia , Carcinoma/terapia , Infecciones por VIH/diagnóstico , Infecciones por VIH/tratamiento farmacológico , Neoplasias de la Vulva/terapia , Administración Tópica , Aminoquinolinas/administración & dosificación , Fármacos Anti-VIH/uso terapéutico , Neoplasias del Ano/patología , Carcinoma/patología , Niño , Terapia Combinada , Femenino , Estudios de Seguimiento , Infecciones por VIH/inmunología , Seropositividad para VIH , Humanos , Imiquimod , Huésped Inmunocomprometido , Terapia por Luz de Baja Intensidad/métodos , Infecciones por Papillomavirus/patología , Infecciones por Papillomavirus/terapia , Medición de Riesgo , Resultado del Tratamiento , Neoplasias de la Vulva/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA